Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background/aim: Antimitochondrial antibody (AMA) positivity is the serological marker of primary biliary cholangitis (PBC), but can also be sporadically detected in autoimmune hepatitis (AIH). Little is known about the clinical significance of AMA in AIH. Patients and methods: We recruited 47 AMA-positive AIH cases from several centres and compared them with 264 well-characterized Italian AIH patients. Cases with any features of PBC were excluded. Results: In univariate analysis, AMA-positive AIH patients were older (46 vs. 36, P =0.002) and more responsive to immunosuppression (74 vs. 59%, P =0.05), but no differences were observed between the two groups after logistic regression using AMA as a dependent variable. None of the AMA-positive AIH patients showed signs of evolving PBC features after a median follow-up of up 47 months. AMA was detected in combination with all serological AIH markers except antiliver kidney microsome type 1 and antiliver cytosol type 1. AMA was the only marker of autoimmunity in eight cases. Conclusion: We found no differences between AIH with and without AMA. The groups had similar clinical, biochemical and histological features. AMA-positive AIH patients did not evolve towards PBC. In some cases, AMA was the only autoantibody.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are case reports of patients with overt AIH who nevertheless tested AMA positive, (138)(139) but on long-term follow-up, these patients do not develop PBC.(136,140)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [140]
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Natural history of early primary biliary cirrhosis
Metcalf, J. V., Mitchison, H. C., Palmer, J. M., Jones, D. E., Bassendine, M. F., & James, O. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04410-8 · Cited by 421
Frequency and nature of the variant syndromes of autoimmune liver disease
Czaja, A. J. (1998) · Hepatology · doi:10.1002/hep.510280210 · Cited by 343
Autoimmune acute liver failure: Proposed clinical and histological criteria
Stravitz, R. T., Lefkowitch, J. H., Fontana, R. J., Gershwin, M. E., Leung, P. S. C., Sterling, R. K., Manns, M. P., Norman, G. L., Lee, W. M., & and the Acute Liver Failure Study Group (2011) · Hepatology · doi:10.1002/hep.24080 · Cited by 303
Mitchison, H. C., Bassendine, M. F., Hendrick, A., Bennett, M. K., Bird, G., Watson, A. J., & James, O. F. W. (1986) · Hepatology · doi:10.1002/hep.1840060609 · Cited by 230
Review article: autoimmune hepatitis - current management and challenges
Zachou, K., Muratori, P., Koukoulis, G. K., Granito, A., Gatselis, N., Fabbri, A., Dalekos, G. N., & Muratori, L. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12470 · Cited by 179
Self-citationChanging Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.031 · Cited by 172
Cited by
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Lammert, C., Zhu, C., Lian, Y., Raman, I., Eckert, G., Li, Q., & Chalasani, N. (2020) · Hepatology Communications · doi:10.1002/hep4.1582 · Cited by 38
Metadata
- Authors
- Muratori, P., Efe, C., Muratori, L., Ozaslan, E., Schiano, T., Yoshida, E. M., Heurgué-Berlot, A., Lalanne, C., Lenzi, M., & Wahlin, S.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Hacettepe University (TR)
- Department of Gastroenterology, Numune Education and Research Hospital, Ankara, Turkey
- Mount Sinai Hospital (US)
- University of British Columbia (CA)
- Department of Hepato-Gastroenterology, CHU Reims, Reims, France
- Department of Gastroenterology and Hepatology, Hepatology Division, Centre for Digestive Disease, Karolinska Institute, Stockholm, Sweden
- Corresponding author
- Muratori, Paolo
- Muratori, Luigi
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2017-07
- Volume
- 29
- Issue
- 7
- Pages
- 777-780
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2602518144
- Cited by
- 19
- References
- 29
- Citations by year
- 2025: 2 · 2023: 3 · 2022: 4 · 2020: 1 · 2019: 4 · 2018: 4 · 2017: 1
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- antimitochondrial antibodies, autoimmune hepatitis, primary biliary cirrhosis, serological markers, autoantibodies, disease progression
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Autoantibodies, Child, Child, Preschool, Cholangitis, Europe, Female, Humans, Immunosuppressive Agents, Male, Middle Aged, Mitochondria, North America, Serologic Tests, Biomarkers, Chi-Square Distribution, Logistic Models, Case-Control Studies, Treatment Outcome, Hepatitis, Autoimmune, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. https://app.cochat.ai/papers/10.1097/meg.0000000000000870
- The paper
- Muratori, P., Efe, C., Muratori, L., Ozaslan, E., Schiano, T., Yoshida, E. M., Heurgué-Berlot, A., Lalanne, C., Lenzi, M., & Wahlin, S. (2017). Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000000870
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.